Frazier Healthcare Partners Acquires MatrixCare from ResMed
Private equity firm Frazier Healthcare Partners is acquiring MatrixCare, a post-acute care software provider, from medical device maker ResMed.
Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare sector, has reached an agreement to acquire MatrixCare from ResMed, the sleep and respiratory health device company. The deal marks a notable portfolio shift for ResMed, which had previously expanded into health informatics software as a complement to its core hardware business.
MatrixCare is a well-established software platform serving the post-acute and long-term care market, providing electronic health records and care management tools to skilled nursing facilities, home health agencies, and senior living communities. Its departure from ResMed's portfolio suggests the device maker may be refocusing capital and strategic attention on its primary medical equipment and digital health businesses.
Read more Arthur J. Gallagher Acquires Canadian Broker Wilson M. Beck →
For Frazier Healthcare Partners, the acquisition deepens its footprint in healthcare technology at a time when post-acute care software is under increasing demand pressure. An aging U.S. population and ongoing shifts toward value-based care models have elevated the strategic importance of platforms that coordinate care outside of hospital walls, making MatrixCare a compelling asset for a specialized healthcare investor.
The transaction also reflects broader private equity appetite for healthcare IT assets, particularly those with recurring software revenue and defensible market positions in niche care settings. While specific financial terms of the deal were not disclosed, the move positions Frazier to leverage MatrixCare's established customer base and potentially accelerate product development investment.
Continue reading at SeekingAlpha.
